Who doesn’t love a good coincidence theory?!

JBS @ WEF

BETWEEN HYSTERICALS ABOUT RUSSIAN HACKERS, WEF MEMBERS GATHER UNDER RUSSIAN HELMS TO WORK ON THE CYBER GREAT RESET

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

“The greatest conspiracies are in plain sight” – Edward Snowden

I’ve just unearthed a series of videos that show an unpublicized side of the World Economic Forum and its leader Klaus Schwab.

These videos are extra bonuses to a 2019 German Documentary titled “Das Forum” (The Forum), which seems part of Klaus Schwab’s idea of imprinting his personal image in history for the 50th WEF anniversary.

In 2018, Schwab decided to allow a carefully selected outsider in his kitchen, in a mutually complicit attempt at positive publicity and fame. There are precedents in history. What followed was quite a disaster, in my personal opinion, because Klaus doesn’t have the subtlety needed to do this and it all derailed in a blatant bad-taste cult of personality. All under the disguise of investigative journalism, of course.

I have previously published some of these extras, but now I have the full package and we’re going to weed out the propaganda looking for real truth gems.

From this first video we find out about the so called “Young Global Leaders”, which are pretty clearly World Economic Forum’s youth elite organization. I don’t have yet a quality translation of the part in German, but the English dialogue in the beginning is quite telling.

The second video reveals shocking former Young Global Learders names, and possible new candidates (as of 2018)

In the video above, Putin confirms Blair is one of his “good friends”. Recorded 10 years ago, when they were fresh YGL alumni.

In this third “resurrected” video, we watch them openly discussing regime change in countries unaligned with WEF’s “democratic liberalism” and the Fourth Industrial Revolution

Welcome to the younger Forum!

No one’s younger than the king and his heirs, right?

Young Global Leaders

The Young Global Leaders, or Forum of Young Global Leaders, is an independent non-profit organization managed from GenevaSwitzerland, under the supervision of the Swiss government.

History

Launched by Klaus Schwab of the World Economic Forum in 2004, the Young Global Leaders are governed by a board of twelve world and industry leaders, ranging from Queen Rania of Jordan to Marissa Mayer of Yahoo! and Wikipedia co-founder Jimmy Wales. Schwab created the group with $1 million won from the Dan David Prize, and the inaugural 2005 class comprised 237 young leaders. Young Global Leaders participate in the Annual Meeting of the New Champions, established in 2007 and known informally as “Summer Davos“, alongside Global Growth Companies and other delegations to the World Economic Forum.

Papa Schwab welcomes his “Young Global Leaders” at their Inaugural Summit in 2005

Reception

BusinessWeeks Bruce Nussbaum describes the Young Global Leaders as “the most exclusive private social network in the world”, while the organization itself describes the selected leaders as representing “the voice for the future and the hopes of the next generation”.

Selection process

Representing over 70 different nations, Young Global Leaders are nominated by alumni to serve six-year terms and are subject to veto during the selection process. Candidates must be younger than 38 years old at the time of acceptance (meaning active YGLs are 44 and younger), and highly accomplished in their fields. Over the years, there have been hundreds of honorees, including several popular celebrities, alongside recognized high achievers and innovators in politics, business, academia, media, and the arts.

Members and alumni

Notable members and alumni of Young Global Leaders include:

Young Global Leader David Rothschild, fresh off the YGL boat, preaching the WEF gospel on TV

More American horsemen of the Great Reset

Let’s look at more celebrity YGL’s

Interestingly enough, Daniel Crenshaw has been deleted from their website. But not from the Internet Archive 😉

Crenshaw is also confirmed by this CNBC report

Dude doesn’t even look alive

Young Global Leaders–Anderson Cooper and Leonardo DiCaprio Are In The Most Exclusive Private Social Network In The World.

By Bloomberg, March 18, 2008, 4:00 AM GMT

The World Economic Forum out of Davos just announced its new 2008 list of YGLs—Young Global Leaders. In a growing universe of private social networks, the YGL network has got to be one of—if not THE—most exclusive sn around. A few weeks ago, I predicted that Cameron Sinclair, who founded Architecture for Humanity  would become a YGL—and he did.

YGL website profile

YGLers can find out who fellow members of the social network are in any particular city around the world by clicking on the map site (can’t do it here, sorry). Works for regions too. Want to chat with a fellow YGLer if you’re visiting Silicon Valley, call up Marc Benioff, Shai Agassi, Sergey Brin (Google founder), Gavin Newson (San Fran mayor), Jerry Yang or John Battelle. If you’re in New York City, Business News TV star Maria Bartiromo is a YGLer.

CLICK HERE TO WATCH THE FULL INTERVIEW: Google founder and Young Global Leader Sergey Brin and Klaus Schwab discuss a world without elections, redefining humanity and government

Fellowship Supporters

  • Aliko Dangote Foundation

Executive Education Partners and Supporters

  • Bill and Penny George
  • David Rubenstein
  • Harvard Kennedy School
  • Howard Cox
  • Nanyang Technological University, Singapore
  • Marilyn Carlson Nelson and Glen Nelson
  • Princeton University Andlinger Center for Energy and the Environment
  • Singapore Economic Development Board
  • University of Oxford Saïd Business School
  • University of Cape Town Graduate School of Business
  • Willis Towers Watson

Endowment Supporters (gifts from YGL members of 50,000+ CHF)

The YGL Endowment Fund was created by the community’s members to support the long-term ambitions of the Forum of Young Global Leaders. Its proceeds are intended to support the community programming and to ensure participation is accessible to all members.

  • Andrew Cohen
  • Ellana Lee
  • Georges Kern
  • Henrik Naujoks
  • Jill Otto
  • Katherine Garrett-Cox
  • M Arsjad Rasjid Mangkuningrat
  • Peter Lacy
  • Richard Stromback
  • Ron Cao
  • Sandro Salsano
  • Thor Björgolfsson
  • Veronica Colondam
  • Yana Peel
  • Zhang Yi-Chen

About us

Our growing membership of more than 1,400 members and alumni of 120 nationalities includes civic and business innovators, entrepreneurs, technology pioneers, educators, activists, artists, journalists, and more.

Aligned with the World Economic Forum’s mission, we seek to drive public-private co-operation in the global public interest. We are united by the belief that today’s pressing problems present an opportunity to build a better future across sectors and boundaries.

History

Klaus Schwab, Founder and Executive Chairman of the World Economic Forum, created the Forum of Young Global Leaders in 2004 to help the world meet increasingly complex and interdependent problems. His vision was to create a proactive multistakeholder community of the world’s next-generation leaders to inform and influence decision-making and mobilize transformation.

Through the Forum of Young Global Leaders, Klaus Schwab envisioned facilitating earnest dialogue and friendships across cultures to bridge divides, fostering fresh thinking and dynamic new ways of collaboration to shape a more positive, peaceful and prosperous society.

Annual Reports

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

In November 2020, I anticipated Biden’s takeover of the White House against the vote, based solely on the fact that he is one of the most appreciated troopers at Davos, as opposed to Trump. And that’s where, for over two decades, they’ve developed and coordinated a long term plan for the corporate take-over of elected governance across the entire world. That plan is too big to fail, especially due to some soft opposition from another corporate stooge such as Trump.
The Great Reset is not some looney vision of the future from some eccentric billionaire, as Tucker Calson or SkyNews may present it. It’s an old and lengthy process that’s about to be concluded this decade.

My challenge for the US electors in November 2020

In this report we reveal, in the simplest most accessible terms. how this scheme achieves the intermediary goal of transferring assets and wealth from ignorant plebs to corporate overlords.

This report is in video format.

NB: Why did I say earlier “intermediary goal”? What’s the endgame behind that? Why do these people want more, when they have more than they can enjoy in many generations to come?
All these questions might have a simple answer:
It’s not about wealth anymore. Money is for poor people nowadays. Assets are for rich people. But for the decision-making money-printing overlords, it’s about self-preservation at this point. They went too far and they know they’re over if the population gets out of their control.
Material de-possession is part of a strategy of disempowering their main potential threat at this point – you, I, us. We could all have everything right now. But then many of us could gain the power to figure out what they’ve been up to lately and we could even have the power to do something about it. And that would be the end of them.
So they’re resetting us back into the Dark Ages, but with Star Trek technology.
“Techno-feudalism”, as I called it last year, and Varoufakis used exactly the same words in an interview, to my satisfaction.

This has been taken down since, but they forgot the pdf, got it RIGHT HERE
This got deleted after a backlash, but too late

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

If you’re familiar with our reports, George Church is no stranger to you either. He’s a founder figure for the Human Genome Project, CRISPR and The BRAIN Initiative. But he’s totally not getting the deserved attention, seeing that he’s just turned our world upside down. Not by himself, of course.

Remember when Fauci and Big Tech joined efforts to keep us in the dark in regards to the mRNA impact on our genetics and DNA?


We’ve shown that there’s an entire new field of science that does just that: argues what Fauci said using RNA to reprogram DNA.
But we’ve just reached a deeper level of the rabbit hole that we didn’t even know it’s there already. It’s been there for a while. As in 2020 minus “three years of stealth operations”. If you read carefully below, it will all make much more sense.

George M. Church biography as per Harvard website

Professor at Harvard & MIT, co-author of 580 papers, 143 patent publications & the book “Regenesis”; developed methods used for the first genome sequence (1994) & million-fold cost reductions since (via fluor-NGS & nanopores), plus barcoding, DNA assembly from chips, genome editing, writing & recoding; co-initiated BRAIN Initiative (2011) & Genome Projects (GP-Read-1984, GP-Write-2016, PGP-2005:world’s open-access personal precision medicine datasets); machine learning for protein engineering, tissue reprogramming, organoids, xeno-transplantation, in situ 3D DNA, RNA, protein imaging.

SEE MORE

George Church is Professor of Genetics at Harvard Medical School and Director of  PersonalGenomes.org, which provides the world’s only open-access information on human Genomic, Environmental & Trait data (GET). His 1984 Harvard PhD included the first methods for direct genome sequencing, molecular multiplexing & barcoding. These led to the first genome sequence (pathogen, Helicobacter pylori) in  1994 . His innovations have contributed to nearly all “next generation” DNA sequencing methods and companies (CGI-BGI, Life, Illumina, Nanopore). This plus his lab’s work on chip-DNA-synthesis, gene editing and stem cell engineering resulted in founding additional application-based companies spanning fields of medical diagnostics ( Knome/PierianDxAlacrisAbVitro/JunoGenosVeritas Genetics ) & synthetic biology / therapeutics ( JouleGen9EditasEgenesisenEvolvWarpDrive ). He has also pioneered new privacybiosafetyELSIenvironmental & biosecurity policies. He is director of an IARPA BRAIN Project and NIH Center for Excellence in Genomic Science. His honors include election to NAS & NAE & Franklin Bower Laureate for Achievement in Science. He has coauthored 537 papers156 patent publications & one book (Regenesis).

THIS IS BGI
THIS IS ILLUMINA

PhD students from (* = main training programs for our group):
Harvard University: Biophysics* , BBS* , MCB , ChemBio* , SystemsBio* , Virology
MIT: HST*ChemistryEE/CSPhysicsMath.
Boston Universty: BioinformaticsBiomedical Engineering
Cambridge University, UK: Genetics

PublicationsCVs-resumesLab members , Co-author netELSI
Technology transfer & Commercial Scientific Advisory Roles
Personal info — News — Awards — Grant proposals
Director of Research Centers: DOE-Biotechnologies (1987), NIH-CEGS (2004), PGP (2005), Lipper Center for Computational Genetics (1998), Wyss Inst. Synthetic Biology (2009). Other centers: Regenesis Inst. (2017), SIAT Genome Engineering (2019), Space Genetics (2016), WICGR, Broad Inst. (1990), MIT Media Lab (2014)

Updated: 15-Jan-02021

The BRAIN initiative[edit]

He was part of a team of six[80] who, in a 2012 scientific commentary, proposed a Brain Activity Map, later named BRAIN Initiative (Brain Research through Advancing Innovative Neurotechnologies).[81] They outlined specific experimental techniques that might be used to achieve what they termed a “functional connectome“, as well as new technologies that will have to be developed in the course of the project,[80] including wireless, minimally invasive methods to detect and manipulate neuronal activity, either utilizing microelectronics or synthetic biology. In one such proposed method, enzymatically produced DNA would serve as a “ticker tape record” of neuronal activity.Wikipedia

SEE THE NAZI ORIGINS OF WYSS HERE

Wyss Institute Will Lead IARPA-Funded Brain Mapping Consortium

January 26, 2016

(BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University today announced a cross-institutional consortium to map the brain’s neural circuits with unprecedented fidelity. The consortium is made possible by a $21 million contract from the Intelligence Advanced Research Projects Activity (IARPA) and aims to discover the brain’s learning rules and synaptic ‘circuit design’, further helping to advance neurally-derived machine learning algorithms.

The consortium will leverage the Wyss Institute’s FISSEQ (fluorescent in-situ sequencing) method to push forward neuronal connectomics, the science of identifying the neuronal cells that work together to bring about specific brain functions. FISSEQ was developed in 2014 by the Wyss Core Faculty member George Church and colleagues and, unlike traditional sequencing technologies, it provides a method to pinpoint the precise locations of specific RNA molecules in intact tissue. The consortium will harness this FISSEQ capability to accurately trace the complete set of neuronal cells and their connecting processes in intact brain tissue over long distances, which is currently difficult to do with other methods.

Awarded a competitive IARPA MICrONS contract, the consortium will further the overall goals of President Obama’s BRAIN initiative, which aims to improve the understanding of the human mind and uncover new ways to treat neuropathological disorders like Alzheimer’s disease, schizophrenia, autism and epilepsy. The consortium’s work will fundamentally innovate the technological framework used to decipher the principal circuits neurons use to communicate and fulfill specific brain functions. The learnings can be applied to enhance artificial intelligence in different areas of machine learning such as fraud detection, pattern and image recognition, and self-driving car decision making.

See how the Wyss-developed FISSEQ technology is able to capture the location of individual RNA molecules within cells, which will allow the reconstruction of neuronal networks in the 3-dimensional space of intact brain tissue. Credit: Wyss Institute at Harvard University

“Historically, the mapping of neuronal paths and circuits in the brain has required brain tissue to be sectioned and visualized by electron microscopy. Complete neurons and circuits are then reconstructed by aligning the individual electron microsope images, this process is costly and inaccurate due to use of only one color (grey),” said Church, who is the Principal Investigator for the IARPA MICrONs consortium. “We are taking an entirely new approach to neuronal connectomics_immensely colorful barcodes_that should overcome this obstacle; and by integrating molecular and physiological information we are looking to render a high-definition map of neuronal circuits dedicated first to specific sensations, and in the future to behaviors and cognitive tasks.”

Church is Professor of Genetics at Harvard Medical School, and Professor of Health Sciences and Technology at Harvard and MIT.

To map neural connections, the consortium will genetically engineer mice so that each neuron is barcoded throughout its entire structure with a unique RNA sequence, a technique called BOINC (Barcoding of Individual Neuronal Connections) developed by Anthony Zador at Cold Spring Harbor Laboratory. Thus a complete map representing the precise location, shape and connections of all neurons can be generated.

The key to visualizing this complex map will be FISSEQ, which is able to sequence the total complement of barcodes and pinpoint their exact locations using a super-resolution microscope. Importantly, since FISSEQ analysis can be applied to intact brain tissue, the error-prone brain-sectioning procedure that is part of common mapping studies can be avoided and long neuronal processes can be more accurately traced in larger numbers and at a faster pace.

In addition, the scientists will provide the barcoded mice with a sensory stimulus, such as a flash of light, to highlight and glean the circuits corresponding to that stimulus within the much more complex neuronal map. An improved understanding of how neuronal circuits are composed and how they function over longer distances will ultimately allow the team to build new models for machine learning.

The multi-disciplinary consortium spans 6 institutions. In addition to Church, the Wyss Institute’s effort will be led by Samuel Inverso, Ph.D., who is a Staff Software Engineer and Co-investigator of the project. Complementing the Wyss team, are co-Principal Investigators Anthony Zador, Ph.D., Alexei Koulakov, Ph.D., and Jay Lee, Ph.D., at Cold Spring Harbor Laboratory. Adam Marblestone, Ph.D., and Liam Paninski, Ph.D. are co-Investigator at MIT and co-Principal Investigator at Columbia University, respectively. The Harvard-led consortium is partnering with another MICrONS team led by Tai Sing Lee, Ph.D. of Carnegie Mellon University as Principal investigator under a separate multi-million contract, with Sandra Kuhlman, Ph.D. of Carnegie Mellon University and Alan Yuille, Ph.D. of Johns Hopkins University as co-Principal investigators, to develop computational models of the neural circuits and a new generation of machine learning algorithms by studying the behaviors of a large population of neurons in behaving animals, as well as the circuitry of the these neurons revealed by the innovative methods developed by the consortium.

“It is very exciting to see how technology developed at the Wyss Institute is now becoming instrumental in showing how specific brain functions are wired into the neuronal architecture. The methodology implemented by this research can change the trajectory of brain mapping world wide,” said Wyss Institute Founding Director Donald Ingber, M.D., Ph.D., who is also the Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital and Professor of Bioengineering at the Harvard John A. Paulson School of Engineering and Applied Sciences. – WYSS Institute

IARPA is CIA’s DARPA.
DARPA IS RAN BY PENTAGON AND IARPA BY CIA.
IARPA IS EVEN MORE SECRETIVE, DARING AND SOCIOPATHIC.

Machine Intelligence from Cortical Networks (MICrONS)

Intelligence Advanced Research Projects Activity (IARPA)

Brain Research through Advancing Innovative Neurotechnologies. (BRAIN)

Background
The science behind Obama’s BRAIN project. (BrainFacts, 15Apr-2013 | Jean-François Gariépy)
Wyss Institute Will Lead IARPA-Funded Brain Mapping Consortium (Wyss, 26-Jan-2016 |)
Project Aims to Reverse-engineer Brain Algorithms, Make Computers Learn Like Humans (Scientific Computing, 4-Feb-2016 | Byron Spice)
The U.S. Government Launches a $100-Million “Apollo Project of the Brain” (Scientific American, 8-Mar-2016 | Jordana Cepelewicz)

Grant Proposal
Tasks 2 & 3 PDF Harvard, Wyss, CSHL, MIT.
Task 1. CMU.


Molecular TickertapeRelated Projects:

Full Rosetta brains in situ
A. Activity (MICrONS = Ca imaging) (Alternative=Tickertape, see figure to right)
B. Behavior (MICrONS & Alt = traditional video)
C. Connectome (MICrONS & Alt = BOINC via Cas9-barcode)
D. Developmental Lineage (via Cas9-barcode)
E. Expression (RNA & Protein via FISSEQ)

Building brain components, circuits and organoids.
Busskamp V, Lewis NE, Guye P, Ng AHM, Shipman S, Byrne SS, Sanjana NE, Li Y, Weiss R, Church GM (2014)
Rapid neurogenesis through transcriptional activation in human stem cells. Molecular Systems Biology MSB 10:760:1-21

SOURCE

Flagship Pioneering’s Scientists Invent a New Category of Genome Engineering Technology: Gene Writing

Tessera Therapeutics emerges from three years of stealth operations to pioneer Gene Writing™ as a new genome engineering technology and category of genetic medicine

(PRNewsfoto/Flagship Pioneering)

NEWS PROVIDED BY Flagship Pioneering 

Jul 07, 2020, 08:00 ET


CAMBRIDGE, Mass., July 7, 2020 /PRNewswire/ — Flagship Pioneering today announced the unveiling of Tessera Therapeutics, Inc. a new company with the mission of curing disease by writing in the code of life. Tessera is pioneering Gene Writing™, a new biotechnology that writes therapeutic messages into the genome to treat diseases at their source.

Tessera’s Gene Writing platform is a potentially revolutionary breakthrough for genetic medicine that addresses key limitations of gene therapy and gene editing. Gene Writing technology can alter the genome by efficiently inserting genes and exons (parts of genes), introducing small insertions and deletions, or changing single or multiple DNA base pairs. The technology could enable cures for diseases that arise from errors in the genome, including monogenic disorders. It could also allow precise gene regulation in other diseases such as neurodegenerative diseases, autoimmune disorders, and metabolic diseases.

“While profound advancements in genetic medicine over the last two decades had therapeutic promise for many previously untreatable diseases, the intrinsic properties of existing gene therapy and editing have significant shortcomings that limit their benefits to patients,” says Noubar Afeyan, Ph.D., founder and CEO of Flagship Pioneering and Chairman of Tessera Therapeutics. “Our scientists have invented a new technology, called Gene Writing, that has the ability to write therapeutic messages into the genomes of somatic cells. We created Tessera to pioneer its applications for medicine. However, the breakthrough is broad and could be applied to many different genomes from humans to plants to microorganisms.”

A New Era of Genetic Medicine

Geoffrey von Maltzahn, Ph.D., an MIT-trained biological engineer; Jacob Rubens, Ph.D., an MIT-trained synthetic biologist; and other scientists at Flagship Labs, the enterprise’s innovation foundry, co-founded Tessera in 2018 to create a platform that could design, make, and launch Gene Writing medicines. A General Partner at Flagship Pioneering, von Maltzahn has co-founded numerous biotechnology companies, including Sana Biotechnology, Indigo Agriculture, Kaleido Biosciences, Seres Therapeutics, and Axcella Health.

“DNA codes for life. But sometimes our DNA is written improperly, driving an enormous variety of diseases,” says von Maltzahn, Tessera’s Chief Executive Officer. “We started Tessera Therapeutics with a simple question: ‘What if Nature evolved a better solution than CRISPR for inserting curative therapeutic messages into the genome?’ It turns out that engineered and synthetic mobile genetic elements offer the potential to go beyond the limitations of gene editing technologies and allow Gene Writing. Our outstanding team of scientists is focused on bringing the vast promise of this new technology category to patients.”

Mobile genetic elements, the inspiration for Gene Writing, are evolution’s greatest genomic architect. The first mobile genetic element was discovered by Barbara McClintock, who won the 1983 Nobel Prize for revealing the mobile nature of genes. Mobile genetic elements code for the machinery to move or copy themselves into a new location in the genome, and they have been selected over billions of years to autonomously and efficiently “write” their DNA into new genomic sites. Today, mobile genetic elements are among the most abundant and ubiquitous genes in nature.

Over the past two years, Tessera has been mining genomes to discover novel mobile genetic elements and engineering them to create Gene Writing technology.

Tessera’s Gene Writers write therapeutic messages into the genome using RNA or DNA templates. RNA-based Gene Writing uses an RNA template and Gene Writer protein to either write a new gene into the genome or guide the rewriting of a pre-existing genomic sequence to make a small substitution, insertion, or deletion. DNA-based Gene Writing uses a DNA template to write a new gene into the genome.

By harnessing the biology of mobile genetic elements, Gene Writing holds the potential to overcome the limitations of current genetic medicine approaches by:

  • Efficiently writing small and large alterations to the genome of somatic cells with minimal reliance upon host DNA repair pathways, unlike nuclease-based gene editing technologies.
  • Permanently adding new DNA to dividing cells, unlike AAV-based gene therapy technologies.
  • Writing new DNA sequences into the genome by delivering only RNA.
  • Allowing repeated administration of treatments to patients in order to dose genetic medicines to effect, which is not possible with current gene therapies.

Tessera has licensed Flagship Pioneering’s intellectual property estate, which was begun in 2018 with seminal patent filings supporting both RNA and DNA Gene Writing technologies.

Tessera’s Scientific Advisory Board includes Luigi Naldini, David Schaffer, Andrew Scharenberg, Nancy Craig, George Church, Jonathan Weissman, and John Moran, who collectively have decades of experience in developing gene therapies and gene editing technologies, and also have commercial expertise from 4D, UniQure, Casebia, Cellectis, Magenta, and Editas. Tessera’s Board of Directors includes John Mendlein, Flagship Executive Partner and former CEO of multiple companies; Melissa Moore, Chair of Tessera’s Scientific Advisory Board, Chief Scientific Officer of Moderna, member of the National Academy of Sciences, and founding co-director of the RNA Therapeutics Institute; Geoffrey von Maltzahn; and Noubar Afeyan. The 30-person R&D team at Tessera has deep genetic medicine and startup expertise, including alumni from Editas, Intellia, Beam, Casebia, and Moderna.

About Tessera Therapeutics
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the ability to write and rewrite small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing, while eliminating important limitations in their reach, utilization and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-class category companies to transform human health and sustainability.

About Flagship Pioneering
Flagship Pioneering conceives, creates, resources, and develops first-in-category life sciences companies to transform human health and sustainability. Since its launch in 2000, the firm has applied a unique hypothesis-driven innovation process to originate and foster more than 100 scientific ventures, resulting in over $34 billion in aggregate value. To date, Flagship is backed by more than $4.4 billion of aggregate capital commitments, of which over $1.9 billion has been deployed toward the founding and growth of its pioneering companies alongside more than $10 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 transformative companies, including Axcella Health (NASDAQ: AXLA), Denali Therapeutics (NASDAQ: DNLI), Evelo Biosciences (NASDAQ: EVLO), Foghorn Therapeutics, Indigo Ag, Kaleido Biosciences (NASDAQ: KLDO), Moderna (NASDAQ: MRNA), Rubius Therapeutics (NASDAQ: RUBY), Sana Biotechnology, Seres Therapeutics (NASDAQ: MCRB), and Syros Pharmaceuticals (NASDAQ: SYRS). – Flagship Pioneering

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

You can always build better anything, but you can only build back better something that’s not there anymore. You can build back an order only out of chaos. As in “ordo ab chao”.

the symbolic significance of the motto ‘Ordo ab Chao’

Within Freemasonry, few themes are more essential to understanding the fraternity than light and darkness. Joining Freemasonry is seen as the process of being welcomed into the light and an act from which one can deliver themselves from darkness and become spiritually and morally awakened.

Within the same framework, one can see their joining of Freemasonry as their delivery from chaos and an opportunity to build a better life based on the critical Masonic values and life lessons.

As has been explored, order and chaos are not static entities but are complexly intertwined and evolve over time. For a Mason, the intersectionality of order and chaos is imperative to understand if one is to grow and become a better person.

From such consideration, it is clear to see why the Masonic motto ‘Ordo ab Chao’ has such significance and is widely emblazoned across Masonic regalia, flags, and symbols the world over.
Source: https://freemasonscommunity.life

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Are you wearing your conspiracy theory “wearables” yet? Get ready to “internalize” them!

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

Sometimes my memes are 3D. And you can own them. Or send them to someone.
You can even eat some of them.
CLICK HERE

You’ve likely heard of IG Farben, bud have you ever heard of American IG and the follow up story?

Imagine that the brutal experiments at Auschwitz were better concealed and the prisoners were drugged and brainwashed to believe that’s the best world out there for them. Then find out that the management has never stopped winning, expanding and perfecting their business model, up to today’s Great Reset.

good stuff that i had to leave out the video documentary:

Rockefellers brought the Nazi doctors and researchers to the US

SOURCE

ANSCO

Founded in Binghamton, New York, in 1901, Ansco was a manufacturer of photographic products and film. Ansco was originally founded through the merger of E. Anthony & Company and Scovill Manufacturing. In 1928, Ansco merged with Agfa to form Agfa-Ansco. The new corporation was a division of General Aniline and Film (GAF) Corporation, which was controlled by the German chemical cartel IG Farben. After Germany declared war on the United States in 1941, the United States Government seized the assets of GAF, including Agfa-Ansco. In 1943, the company removed “Agfa” from its name, once again becoming Ansco. The United States Justice Department oversaw Ansco’s operation until 1965, when government-held stock in GAF was sold to the public. In 1977, GAF eliminated its line of consumer photography products, including those manufactured by Ansco at the Binghamton facility. GAF also sold the Ansco trademark to Haking Enterprises. GAF continued to manufacture film at the Binghamton plant for industrial and medical use until 1981, when it sold the plant to Anitec Image Corporation. Over the next two decades, the former Ansco facility was sold several times, and in 2000, it was demolished.

Prior to the late 1970s, dozens of asbestos-containing materials were utilized in the construction and maintenance of buildings at Ansco’s Binghamton facility, including fireproof insulation, pipe covering and insulating cement. Inhaling dust from the application and removal of asbestos-containing materials placed workers at risk for developing an asbestos-related disease, such as mesothelioma or lung cancer.

Fireproof insulation was applied to structural steel during the construction of buildings at Ansco. Fireproofing materials were manufactured as a dry mixture of asbestos, linen and cement, packaged in fifty-pound paper bags. The dry mixture was mixed with water and sprayed onto the structural steel using a hose. Pouring, mixing and spraying fireproof insulation created clouds of asbestos-containing dust. After the fireproofing material was applied, it was typical for tradesmen, such as electricians or pipefitters, to scrape the fireproofing material from structural steel in order to install pipes and conduits. When the fireproof insulation was disturbed, asbestos fibers and dust became airborne.

Workers applied asbestos-containing pipe covering to pipes at the Binghamton Ansco facility. Pipe covering was applied to numerous piping systems in order to maintain stable internal temperatures and to protect pipes from damage. When pipe covering was applied, asbestos fibers were emitted. Insulating cement was also applied to pumps, valves and other equipment. It was manufactured as a powder and mixed with water to prepare it for application. Mixing insulating cement caused asbestos-containing dust to become airborne.

source:

What’s Bayer been up to lately?
We find out from their website:

The Bio Revolution is redefining innovation in the life sciences. How this might be a game changer.

The life sciences have made great advances in the past years. Biology, life sciences and the megatrend of digitization are growing closer together, enabling new inventions that impact our daily lives in a scope that we speak of a Bio Revolution. This revolution is reinforced by rapid increases in computing power and the emergence of new capabilities in AI, automation, and data analytics. These trends are further accelerating the pace of innovation and the potential for higher R&D productivity in the life sciences.

All this has led to new ways to understand and explore biology. The range of life forms on earth is incredibly complex and diverse. However, the methods to analyze them can be remarkably similar. Technologies and methods are transcending disciplinary boundaries even faster.

The implications across the life sciences can be enormous:

For human health, for example, a deeper understanding of the relationship between genetics and disease has led to the emergence of precision medicine, which can potentially be more effective than the one-size-fits-all therapies of the past. In the future, new technologies could help the healthcare industry not only treat, but cure or even prevent diseases. New gene and cell therapies, for example, aim to cure genetic diseases, potentially enabling sustainable organ replacement or reversing autoimmune diseases.

The Bio Revolution has the potential to help address some of the most critical global challenges, from climate change to pandemics, chronic diseases, and worldwide food security. Experts estimate that a significant portion of the economic impact of biological applications will be in health care, agriculture, and consumer products.3 Already today, the Bio Revolution with its convergence of science and technology has created an explosion of research projects in science and business. Each year, the amount of Intellectual Property related to the Bio Revolution is increasing.4 This can be seen, for example, by the number of patents in CrispR or plant biotech. In short: the revolution is gaining momentum and holds a great promise for health and food alike.

Total number of CRISPR patent applications worldwide per year from 1984 to 2018.

Quote symbolFueled by digitalization, growing connectivity, and falling costs, important advances in biotechnology are intertwined with more systemic shift in how bio-innovation is undertaken and who is involved. Microbiome technologies, advanced genomics, gene editing and synthetic biology are among key enabling technologies that have the potential to change the face of bio-innovation. This broader redefinition of bio-innovation creates new prospects to help address important nutrition, environmental and development needs.

World Economic Forum, Bio-Innovation Dialogue Initiative

.At the Forefront of the Bio Revolution

As a leading life science company, Bayer is aligned with the long-term market trends in health and nutrition and offers innovative and sustainable solutions to tackle some of the key challenges for humanity. Bayer brings to the table an extensive knowledge of human and plant science, supported by its expertise in regulatory processes and an impressive global footprint to ultimately bring innovations from labs to market. https://www.youtube-nocookie.com/embed/EYE1gya7XiM?autoplay=1&start=0&rel=0

The Bio Revolution marks the beginning of a new era: Innovations enabled by the convergence of biology and technology have the potential to significantly improve our lives, our nutrition, and our health.

Did you know that Bayer is at the forefront of the wave of innovation coming from the Bio Revolution?

The Bio Revolution is expected to transform healthcare and agriculture over the next decades – but the revolution is already happening now. With its newly established cell and gene therapy platform in Pharmaceuticals and innovative gene-editing tools such as CRISPR, Bayer operates at the core of the Bio Revolution and has tremendous opportunities to improve health and nutrition.

In Pharma, Bayer’s new Cell & Gene Therapy (CGT) platform steers our strategy in the area and orchestrates our activities along the value chain providing an innovation ecosystem for the companies – including BlueRock Therapeutics and Asklepios BioPharmaceutical (AskBio), which are fully owned by Bayer but operate autonomously. These therapies hold the potential to significantly impact patients’ lives by moving from treating symptoms to potentially curative approaches.

Bayer’s development portfolio of cell and gene therapies already comprises eight advanced assets in different stages of clinical development. These are applicable in multiple therapeutic areas with high unmet need, such as neurodegenerative, neuromuscular and cardiovascular indications, with programs in Pompe disease, Parkinson’s disease, hemophilia A, and congestive heart failure. With over 15 preclinical assets in the cell and gene therapy field, the pipeline is expected to grow steadily year by year.

Yet Bayer is not only using biotechnology to advance health – the promise for agriculture is just as inspiring. In the Crop Science Division, for example, tools like CRISPR can make changes to plant DNA with more precision than ever before and make plants more weather- or disease-resistant, enabling farmers to grow more or better-quality products under changing conditions.

Advancing genetic solutions for a sustainable future (1)PreviousNext

Did you know that Leaps by Bayer invests into potentially disruptive technologies to tackle some of the largest, unsolved challenges in the life sciences?

With Leaps by Bayer – our impact investment approach utilizing venture capital – we are constantly scanning for additional potential breakthroughs that hold promise to either cure or treat people from diseases or help feed a growing population with less impact on the environment.

$1 Billion

Since 2015, Leaps by Bayer has invested over $1 billion in ventures that tackle fundamental breakthroughs and shift core paradigms in our industries.

Leaps by Bayer has an investment focus on potentially disruptive solutions in the fields of healthcare and agriculture. The Leaps investment approach is remarkable: It aims to invest into or build up new innovative companies. Bayer supports those companies by enabling the exchange of proprietary assets, which can include sharing own patents or providing access to the Bayer network’s technical capabilities and 150 years of expertise. The companies remain autonomous with respect to decision making, while Leaps facilitates and supports them in a so-called active incubation process. Experienced team members actively engage in the young companies’ development by providing resources and helping them to steer the initial strategic direction. Today, the investment portfolio includes more than 35 companies advancing potential breakthrough technologies.

Quote symbolLeaps is our way of thinking big.

Werner Baumann, CEO of Bayer AG

Many Leaps ventures have made significant progress towards unlocking the potential of new technology platforms with a promising and transformative potential. BlueRock Therapeutics, for example, started as a Leaps investment and is now an integral part of Bayer’s CGT platform and just received clearance to proceed with a phase I trial in Parkinson’s disease.

Other companies, like the biopharmaceutical player Triumvira, are specialized on next generation immuno-oncology treatments. Triumvira focuses on novel T-cell therapies that aim to be safer and more efficacious than current cell therapy cancer treatments. Treating, curing and preventing cancer is one of the focus areas of Leaps by Bayer, since this group of diseases still represents one of today’s biggest health challenges with limited curative or preventative therapies available.

Quote symbolWe face a huge disease burden, and the way we produce food isn’t sustainable for the planet. I believe the Bio Revolution can help us overcome these issues.

Jürgen Eckhardt, Head of Leaps by Bayer

Leaps is also investing in the development of sustainable biotechnological solutions in the field of agriculture. One of the ventures in this field is Joyn Bio, a company that aims to significantly reduce the environmental impact of synthetic nitrogen fertilizers through a technology that fixes nitrogen into the soil. Nitrogen is one of the most important nutrients essential for every plant to grow, however, its use and production as a fertilizer is estimated to contribute 3-5% to all global greenhouse gas emissions. Joyn Bio is working on an engineered microbe that enables cereal crops like corn, wheat, and rice to convert nitrogen from the air into a form they can use to grow. This technology may have the potential to help farmers use nitrogen in new ways, and as a result, reduce agriculture’s environmental footprint.

Leaps portfolio

The Leaps by Bayer investment portfolio includes more than 35 companies.

At least that’s what Bayer says. All I know is that they’re still running the show.

Ex-Standard Oil

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!

If you enabled this Covidiocracy in any way, I’m sorry for you! Even if you have a long life ahead of you, you’ll never experience peace of soul and happiness again.
And in no way you’re welcome to rule over or dictate to any living soul.

BONUS:

DOWNLOAD PDF

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

ORDER

Yes, the vaccine passports too, like many other “novel ideas” brought up by the “novel” Macarenavirus, have been actually planned long ago.

DOWNLOAD PDF FROM EUROPEAN COMMISSION WEBSITE

IN OTHER NEWS

24 world leaders announce international pandemic treaty to implement Great Reset agenda

Signatories include the head of the World Health Organization, as well as the leaders of France, Germany, the U.K., and other countries.

March 31, 2021 (LifeSiteNews) –– A host of global leaders issued a call for a global pandemic treaty, purportedly in order to prevent future pandemics, distribute vaccinations, and implement a unilateral approach to global governance.

U.K. Prime Minister Boris Johnson, French President Emmanuel Macron, German Chancellor Angela Merkel, the head of the World Health Organisation (WHO), as well as 20 other world leaders, joined forces in penning a joint letter with the apparent intent of winning popular support for the globalist plan.

Writing in U.K. paper The Telegraph, as well as other publications such as Le Monde in France, the leaders declared their intent to “build a more robust international health architecture that will protect future generations.”

Calling COVID-19 the “biggest challenge to the global community since the 1940s,” the 24 leaders predicted that there “will be other pandemics and other major health emergencies.”

“No single government or multilateral agency can address this threat alone,” they declared. “The question is not if, but when. Together, we must be better prepared to predict, prevent, detect, assess and effectively respond to pandemics in a highly co-ordinated fashion. The Covid-19 pandemic has been a stark and painful reminder that nobody is safe until everyone is safe.”

This final phrase could indicate the influence which World Economic Forum (WEF) founder and committed globalist Klaus Schwab enjoys over the 24 leaders. Just weeks ago, Schwab declared, “As long as not everybody is vaccinated, nobody will be safe,” a statement which in itself poses an interesting question about the trust which such leaders are placing in their much praised, but dangerousexperimental injections.

The leaders re-affirmed their joint aim of global vaccination, describing it as “global public good.”

In order to achieve that “public good,” and to ensure swift roll-out of vaccines across the globe, the 24 globalists initiated their new international treaty: “[W]e believe that nations should work together towards a new international treaty for pandemic preparedness and response. Such a renewed collective commitment would be a milestone in stepping up pandemic preparedness at the highest political level.”

This treaty would be based on the principles of the WHO, drawing from the WHO’s constitution, as well as calling on “other relevant organisations key to this endeavour.” The WHO’s director-general, Dr. Tedros Adhanom Ghebreyesus, was one of the signatories of the statement.

“The main goal of this treaty would be to foster an all of government and all of society approach, strengthening national, regional and global capacities and resilience to future pandemics,” the leaders declared.

“This includes greatly enhancing international co-operation to improve, for example, alert systems, data-sharing, research and local, regional and global production and distribution of medical and public health counter-measures such as vaccines, medicines, diagnostics and personal protective equipment.”

Nor would it be centered purely on globalist vaccination agendas. Due to the leaders’ “One Health” approach, it would build on the principle of a connection between “the health of humans, animals and our planet.”

In language reminiscent of the Great Reset agendapromoted by the WEF and Klaus Schwab, the leaders mentioned that the new treaty would lead to a lack of national interests, and increased international concerns: “[S]uch a treaty should lead to more mutual accountability and shared responsibility, transparency and co-operation within the international system and with its rules and norms.”

No section of society would be exempt from becoming involved in the new treaty, whatever it may turn out to look like, with the world leaders pointing out that “we will work with heads of state and governments globally, and all stakeholders including civil society and the private sector.”

Declaring that the coronavirus, which originated in Wuhan, China, had “exploited our weaknesses and divisions,” the leaders pronounced it to be their “responsibility” to “ensure that the world learns the lessons of the Covid-19 pandemic,” and to “seize this opportunity and come together as a global community for peaceful co-operation that extends beyond this crisis.”

The proposal is due to be further discussed among national leaders at the June G7 summit in Cornwall in the U.K., where Boris Johnson will join his counterparts from Canada, France, Germany, Italy, Japan, the U.S., and the E.U. Meanwhile, the 24 signatories warned that their new plan “will take time and require a sustained political, financial and societal commitment over many years.”

Speaking to BBC Radio, the WHO’s special COVID envoy Dr. David Nabarro, echoed the language employed by the 24 leaders, noting that it would be 2022 before the globalist agenda of world vaccination was complete, and thus hinted at “all sorts of problems with variants,” before that goal was complete.

The planned treaty appears to align very closely with the Great Reset goals of Klaus Schwab. The World Economic Forum’s promotion of the Reset even employs matching terminology, describing “leaders” who “find themselves at a historic crossroads.”

The societal disruption caused by the Wuhan virus presents “a unique window of opportunity to shape the recovery” for Schwab, who added that “this initiative will offer insights to help inform all those determining the future state of global relations, the direction of national economies, the priorities of societies, the nature of business models and the management of a global commons.”

Indeed, the link between the new international treaty and the Great Reset caused veteran presenter Richie Allen to write, “This is terrifying. For many years, I have been featuring writers, researchers and academics who warned us that this would happen. This is the end game.”

Such a treaty was simply about “concentrating power in the hands of a tiny elite,” explained Allen. “It’s what globalists have been working towards for decades.”

The full list of signatories is found below:

J. V. Bainimarama, prime minister of Fiji; António Luís Santos da Costa, prime minister of Portugal; Klaus Iohannis, president of Romania; Boris Johnson, prime minister of the United Kingdom; Paul Kagame, president of Rwanda; Uhuru Kenyatta, president of Kenya; Emmanuel Macron, president of France; Angela Merkel, chancellor of Germany; Charles Michel, president of the European Council; Kyriakos Mitsotakis, prime minister of Greece; Moon Jae-in, president of the Republic of Korea; Sebastián Piñera, president of Chile; Carlos Alvarado Quesada, president of Costa Rica; Edi Rama, prime minister of Albania; Cyril Ramaphosa, president of South Africa; Keith Rowley, prime minister of Trinidad and Tobago; Mark Rutte, prime minister of the Netherlands; Kais Saied, president of Tunisia; Macky Sall, president of Senegal; Pedro Sánchez, Prime Minister of Spain; Erna Solberg, prime minister of Norway; Aleksandar Vučić, president of Serbia; Joko Widodo, president of Indonesia; Volodymyr Zelensky, president of Ukraine; Dr. Tedros Adhanom Ghebreyesus, director-general of the World Health Organisation.

Our work and existence, as media and people, is funded solely by our most generous readers and we want to keep this way.
But we’re underfunded for June, when we have heavy annual bills to pay for the websites, not counting the countless hours of work. Next target would be adding new features and plugins to the website and better equipment for faster work and more complex video productions.
Help SILVIEW.media survive and grow, please donate here, anything helps. Thank you!

! Articles can always be subject of later editing as a way of perfecting them

We gave up on our profit shares from masks, if you want to help us, please use the donation button!
We think frequent use, even short term use can be bad for you, but if you have no way around them, at least send a message of consciousness.
Get it here!